Between The Lines
A journal club review of “Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in phase 3 randomized clinical trial in patients with narcolepsy,” by Kushida CA, et al.
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts NDA for Priority Review: Centanafadine for Treatment of ADHD
2
Treating Inflammation to Relieve Depression, Anhedonia
3
International Holocaust Remembrance Day and Our Long Road Trip
4
Type C Meeting With FDA Completed for Zervimesine in Dementia With Lewy Bodies
5